 |
|
Prevalence of Hepatitis C in a Chemically Dependent Population
Michael I. Fingerhood, MD;
Donald R. Jasinski, MD;
John T. Sullivan, MB ChB
Arch Intern Med. 1993;153(17):2025-2030.
Abstract
Background
Drug abuse is the major risk factor for hepatitis C in the United States. The objective of this study was to determine the prevalence of hepatitis C virus (HCV), to identify risk factors for HCV, and to correlate HCV and liver function in patients presenting for inpatient detoxification of substances of abuse.
Methods
A total of 687 patients were tested for the presence of antibody to HCV (anti-HCV). Histories related to drug use, sexually transmitted diseases, blood transfusion, and human immunodeficiency virus were obtained, as were serum tests for human immunodeficiency virus, syphilis, hepatitis B, aminotransferases, total bilirubin, and alkaline phosphatase.
Results
The overall prevalence of anti-HCV was 63%: 68% in men vs 54% in women (P<.001), with no difference by race. Remarkably, 86% of injecting drug users tested positive for anti-HCV. Identified risk factors for anti-HCV were injecting drug use (P<.001), human immunodeficiency virus infection (P=.003), exposure to hepatitis B virus (P<.001), and a positive rapid plasma reagin test (P=.04). Previous transfusion and history of previous infection with gonorrhea or syphilis did not correlate with the presence of anti-HCV. Patients positive for anti-HCV had significant elevations in aspartate aminotransferase and alanine aminotransferase levels when compared with patients negative for anti-HCV: 50.8 vs 36.7 U/L (P=.002) and 56.0 vs 36.9 U/L (P<.001), respectively.
Conclusion
Injecting drug users have an extremely high prevalence of anti-HCV. This is the first demonstration, to our knowledge, that the presence of anti-HCV in drug users is associated with significantly increased levels of serum aminotransferases.
(Arch Intern Med. 1993;153:2025-2030)
Author Affiliations
From the Department of Medicine, Johns Hopkins University and Francis Scott Key Medical Center, Baltimore, Md.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Factors Associated with Hepatitis C Virus Infection in Injection and Noninjection Drug Users in Italy
Quaglio et al.
Clinical Infectious Diseases 2003;37:33-40.
ABSTRACT
| FULL TEXT
Mortality among Human Immunodeficiency Virus-Infected Patients with Cirrhosis or Hepatocellular Carcinoma Due to Hepatitis C Virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997
Cacoub et al.
Clinical Infectious Diseases 2001;32:1207-1214.
ABSTRACT
| FULL TEXT
Screening for Hepatitis C Virus in a Health Maintenance Organization
Fischer et al.
Arch Intern Med 2000;160:1665-1673.
ABSTRACT
| FULL TEXT
Adolescent Heroin Use: A Review
Schwartz
Pediatrics 1998;102:1461-1466.
ABSTRACT
| FULL TEXT
Hepatitis C in Intravenous Drug Addicts-Reply
Fingerhood
Arch Intern Med 1994;154:1164-1164.
ABSTRACT
Hepatitis C in Intravenous Drug Addicts
Tennant
Arch Intern Med 1994;154:1163-1164.
ABSTRACT
|
